An increasing number of scientific papers discuss the promising therapeutic potential of
cannabidiol (CBD) not only for the treatment of cancer, but also for asthma and …

Colorectal cancer (CRC) remains the third most prevalent cancer and the fourth most
common cause of cancer-related mortality (Mármol et al., 2017). In recent years, the …

Introduction: Glioblastoma (GBM) is the most common invasive brain tumor composed of
diverse cell types with poor prognosis. The highly complex tumor microenvironment (TME) …

High-grade glioma is one of the most aggressive cancers in adult humans and long-term
survival rates are very low as standard treatments for glioma remain largely unsuccessful …

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. The
challenging problem in cancer treatment is to find a way to upregulate radiosensitivity of …

Photodynamic therapy (PDT) and cannabidiol (CBD) have been explored for their potential
in synergistic cancer treatment. In this study, we employed CBD oil as a lipid phase …

In this chapter the state of art of the pre-clinical evidences of cannabidiol (CBD) anti-tumour
effects on different kinds of cancer will be discussed. As you will see in the following …

Background/Aim: Cannabinoids are widely used in the management of pain, nausea and
cachexia in cancer patients. However, there has been no objective clinical evidence of any …

Chemotherapy is one of the therapeutic approaches for cancer treatment and has
demonstrated great success with the introduction of selectively acting molecules against …

In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and
invasiveness in vitro and caused a decrease in the expression of a set of proteins …